Status:
RECRUITING
PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to investigate how prescribed anti-seizure medications (ASMs) affect cortical excitability in adults with epilepsy. The main questions it aims to answer are: 1...
Eligibility Criteria
Inclusion
- Adult patients (≥ 18j) with epilepsy receiving a prescription for an anti-seizure medication for clinical reasons
- Written informed consent
Exclusion
- Presence of any electrical implants (e.g. neurostimulator or drug delivery system) or any metallic implants anywhere in the head (excluding teeth)
- Increased intracranial pressure
- Uncontrolled psychiatric disorder
- Use of any kind of drug or alcohol, nicotine allowed
- For female participants: If pregnancy cannot be ruled out with sufficient certainty, a pregnancy test (urine) will be carried out before using TMS
- Inability to give consent
Key Trial Info
Start Date :
October 21 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2029
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06892457
Start Date
October 21 2024
End Date
October 1 2029
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bern
Bern, Switzerland, 3010